Quality-adjusted life years accrued with cabozantinib in patients with advanced hepatocellular carcinoma (aHCC) in the CELESTIAL trial
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY(2019)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY(2019)